-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

AL Amyloidosis: Advancements and Future Trends on Diagnosis and Individualized Treatment Approaches

Sponsor: educational grants from Alexion Pharmaceuticals, Janssen Biotech Inc., administered by Janssen Scientific Affairs, LLC, and Prothena. Provided by Clinical Care Options, LLC.
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Diseases, Therapies
Friday, December 8, 2023: 3:00 PM-6:00 PM
Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
Angela Dispenzieri, MD, Mayo Clinic
Dispenzieri: Oncopeptides, Sorento: Consultancy; Alnylam, Bristol-Myers Squibb, Janssen, Pfizer, Takeda: Research Funding; Janssen: Membership on an entity's Board of Directors or advisory committees.
Ashutosh D. Wechalekar, MBBS, DM, FRCP, FRCPath, University College London Hospitals
Wechalekar: GSK: Honoraria; Alexion: Honoraria; Attralus: Honoraria; Janssen: Honoraria; Takeda: Other: Travel support; Alexion, Attralus, Janssen, Prothena.: Consultancy.
This interactive symposium will feature presentations and case-based panel discussions with perspectives and treatment recommendations from experts. Participate in our unique "Live Case and Question Submission", forwarding your queries and real-life cases to our faculty for tailor-made insights. Experts will explore the current state of AL amyloidosis treatment, dissect breakthrough clinical evidence, and anticipate evolving strategies into 2024. Key topics include a deep dive into the biology, clinical presentation, and diagnostic approach for AL amyloidosis, a review of the latest treatment guidelines, insights into managing newly diagnosed and relapsed AL amyloidosis, future directions in treatment, and supportive management strategies for improving patients' quality of life. Enrich your understanding, challenge your clinical skills, and contribute to our insightful dialogue on AL amyloidosis in this dynamic, interactive symposium.